Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Buyer's industry: Electromedical & Electrotherapeutic Apparatus

CONMED Corp to acquire Biorez

Announced Aug 1, 2022 · Closed Aug 9, 2022 · Private target

Deal value$85M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash

Transaction

Acquirer
CONMED Corp (CNMD)
Target
Biorez
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Aug 9, 2022

Deal protections

Not disclosed for private-company acquisitions.

Advisors

To the acquirer
Not disclosed
To the target
Canaccord Genuity

Classification

Sector
Healthcare
Buyer's industry
Electromedical & Electrotherapeutic Apparatus
Sources
  • 8-K (EX-99.1) · Aug 2, 2022
  • 8-K (EX-99.1) · Aug 9, 2022

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.